Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report Publisher

Etemadifar M¹ ; Salari M² ; Saeri M³ ; Sigari AA³ ; Ebrahimi Pelarti S³

Source: Clinical Case Reports Published:2021

Abstract

Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear. © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Related Docs

View other Related Docs

1. Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients, Journal of Isfahan Medical School (2016)

2. Efficacy and Safety of Rituximab in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Acta Neurologica Belgica (2023)

3. Efficacy and Safety of Rituximab in Neuromyelitis Optica: Review of Evidence, Journal of Research in Medical Sciences (2017)

Experts (# of related papers)

View all Related Experts

Masoud Etemadifar (2)

Fereshteh Ashtari (1)

Other Related Docs

4. Rituximab Associated Necrosis: A Case Report, Multiple Sclerosis and Related Disorders (2020)

5. Anti-Cd20 Therapies for Pediatric-Onset Multiple Sclerosis: A Systematic Review, Multiple Sclerosis and Related Disorders (2024)

6. Subcutaneous Tocilizumab in Adults With Severe and Critical Covid-19: A Prospective Open-Label Uncontrolled Multicenter Trial, International Immunopharmacology (2020)

7. The Prevalence of Cancer in Patients With Multiple Sclerosis (Ms) Who Received Rituximab: A Systematic Review and Meta-Analysis; [La Prevalencia De Cancer En Pacientes Con Esclerosis Multiple (Em) Que Recibieron Rituximab: Una Revision Sistematica Y Meta-Analisis], Neurologia (2025)

8. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)

Style	Citing Format
MLA	Etemadifar M, et al.. "Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report." Clinical Case Reports, vol. 9, no. 7, 2021, pp. -.
APA	Etemadifar M, Salari M, Saeri M, Sigari AA, Ebrahimi Pelarti S (2021). Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report. Clinical Case Reports, 9(7), -.
Chicago	Etemadifar M, Salari M, Saeri M, Sigari AA, Ebrahimi Pelarti S. "Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report." Clinical Case Reports 9, no. 7 (2021): -.
Harvard	Etemadifar M et al. (2021) 'Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report', Clinical Case Reports, 9(7), pp. -.
Vancouver	Etemadifar M, Salari M, Saeri M, Sigari AA, Ebrahimi Pelarti S. Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report. Clinical Case Reports. 2021;9(7):-.
BibTex	@article{ author = {Etemadifar M and Salari M and Saeri M and Sigari AA and Ebrahimi Pelarti S}, title = {Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report}, journal = {Clinical Case Reports}, volume = {9}, number = {7}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Etemadifar M AU - Salari M AU - Saeri M AU - Sigari AA AU - Ebrahimi Pelarti S TI - Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report JO - Clinical Case Reports VL - 9 IS - 7 SP - EP - PY - 2021 ER -